Campus,Year,Session,Subject,Course,Detail,Section,Title,Professor,Enrolled,Avg,High,Low,<50,50-54,55-59,60-63,64-67,68-71,72-75,76-79,80-84,85-89,90-100,Median,Percentile (75),Percentile (25)
UBCV,2022,W,PHAR,306,,001,Medicinal Chemistry of High-Impact Pharmaceuticals in Major Diseases,Adam Frankel;Brent Page;Simon Wisnovsky,29,77.3,94.0,57.0,0,0,1,1,2,4,2,7,6,3,3,78.0,82.0,70.0
UBCV,2022,W,PHAR,307,,001,Analytical Sciences Theory and Laboratory,Abby Collier;Joel Finbloom;Simon Wisnovsky,28,81.4,88.0,71.0,0,0,0,0,0,1,3,5,9,10,0,81.5,86.0,79.0
UBCV,2022,W,PHAR,540,C,002,Topics in Pharmacology,Guri Giaever;Corey Nislow;Simon Wisnovsky,12,93.2,95.0,90.0,0,0,0,0,0,0,0,0,0,0,12,93.5,95.0,92.0
UBCV,2023,W,GSAT,502,,001,Advanced Concepts in Genome Science and Technology,Martin Hirst;Freda Miller;Peter Stirling;Marco Todesco;Carolina Tropini;Simon Wisnovsky,14,92.69,98.0,80.0,0,0,0,0,0,0,0,0,1,1,11,95.0,96.0,90.0
UBCV,2023,W,PHAR,306,,001,Medicinal Chemistry of High-Impact Pharmaceuticals in Major Diseases,Adam Frankel;Brent Page;Simon Wisnovsky,35,78.94,99.0,56.0,0,0,3,0,2,5,6,4,1,5,9,78.0,89.0,70.5
UBCV,2023,W,PHAR,307,,001,Analytical Sciences Theory and Laboratory,Joel Finbloom;Alexander Smith;Simon Wisnovsky,35,76.83,93.0,57.0,0,0,2,3,0,4,7,4,8,2,5,78.0,82.5,71.5
UBCV,2023,W,PHAR,540,B,001,Topics in Pharmacology,Guri Giaever;Corey Nislow;Simon Wisnovsky,6,92.17,97.0,90.0,0,0,0,0,0,0,0,0,0,0,6,92.0,92.0,90.5
